{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:45:25Z","timestamp":1767134725219,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd004834","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T00:00:00Z","timestamp":1239753600000}}],"reference-count":145,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004834.pub2","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T14:47:32Z","timestamp":1239806852000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Interventions for American cutaneous and mucocutaneous leishmaniasis"],"prefix":"10.1002","author":[{"given":"Urb\u00e0","family":"Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Hospital Plat\u00f3; Department of Dermatology, Research Unit for Evidence-based Dermatology; c\/ Plato 21 Barcelona Spain 08006"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariona","family":"Pinart","sequence":"additional","affiliation":[{"name":"Research Unit for Evidence-based Dermatology, Hospital Plat\u00f3; Department of Dermatology; c\/ Doctor Aiguader 88 Barcelona Catalunya Spain 08003"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Rengifo-Pardo","sequence":"additional","affiliation":[{"name":"The University of Nottingham; c\/o Cochrane Skin Group; King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Macaya","sequence":"additional","affiliation":[{"name":"Bellvitge Hospital; Fleixa Llarga s\/n l'hospitalet de Llobregat; Barcelona Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases initiative (DNDi); 15 Chemin Louis-Dunant Geneva Switzerland 1202"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"Tweed","sequence":"additional","affiliation":[{"name":"The University of Nottingham; c\/o Cochrane Skin Group; King's Meadow Campus Lenton Lane Nottingham UK NG7 2NR"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"10.1002\/14651858.CD004834.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1086\/315082","article-title":"Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony stimulating factor versus stibogluconate alone in the treatment of cutaneous leishmaniasis","volume":"180","author":"Almeida","year":"1999","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine and pentamidine for peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinids\/18.3.381","article-title":"Efficacy of a short course (10 days) of high-dose meglumine antimoniate with or without Interferon-gamma in treating cutaneous leishmaniasis in Guatemala","volume":"18","author":"Arana","year":"1994","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with the paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the intitial treatment of cutaneous lesihmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"CID"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Tropica"},{"issue":"8549","key":"10.1002\/14651858.CD004834.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","article-title":"Safety and efficacy of high-dose sodium stibogluconate therapy of american cutaneous leishmaniasis","volume":"4","author":"Ballou","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"21","author":"Convit","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/infdis\/160.1.104","article-title":"Immunotherapy of localized, intermediate, and diffuse forms of american cutaneous leishmaniasis","volume":"160","author":"Convit","year":"1989","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1590\/S0037-86821996000500007","article-title":"Comparative study of meglumine antimoniate, pentamidine isothionate and aminosidine sulphate in the treatment of primary skin lesions caused by Leishmania (viannia) braziliensis","volume":"29","author":"Correia","year":"1996","journal-title":"Revista da Sociedade Brasilera de Medicina Tropical"},{"issue":"12","key":"10.1002\/14651858.CD004834.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1365-4362.1997.00308.x","article-title":"Evaluating the efficacy of allopurinol for treatment of cutaneous leishmaniasis","volume":"36","author":"D'Oliveira","year":"1997","journal-title":"International Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0012|cit12","first-page":"87","article-title":"Treatment of American Tegumentary Leishmaniasis with N-methyl-glucamine: double-blind study with doses of 14 mg\/kg\/day and 28 mg\/kg\/day of antimoniate","volume":"66","author":"Figueiredo Kopke","year":"1991","journal-title":"Anais Brasileiros de Dermatologia"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4269\/ajtmh.1994.51.77","article-title":"Efficacy of 28-day and 40-day regimens of sodium stibogluconate (pentostam) in the treatment of mucosal leishmaniasis","volume":"51","author":"Franke","year":"1994","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4269\/ajtmh.1991.45.92","article-title":"Placebo controlled treatment of ecuadorian cutaneous leishmaniasis","volume":"45","author":"Guderian","year":"1991","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(94)90237-2","article-title":"Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of american cutaneous leishmaniasis","volume":"88","author":"Hepburn","year":"1994","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/513776","article-title":"Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis","volume":"25","author":"Llanos-Cuentas","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4269\/ajtmh.2007.76.1128","article-title":"Parenteral aminosidine is not effective for peruvian mucocutaneous leishmaniasis","volume":"76","author":"Llanos-Cuentas","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.trstmh.2005.08.011","article-title":"Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy","volume":"100","author":"Lobo","year":"2006","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial","volume":"41","author":"Machado-Pinto","year":"2002","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of american cutaneous leishmaniasis","volume":"326","author":"Martinez","year":"1992","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"Martinez","year":"1997","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Ver\u00e1stegui","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"43-50 (89-153)","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimoniate (glucantime) versus localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"Navin","year":"1990","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0035-9203(97)90290-X","article-title":"Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin","volume":"91","author":"Neva","year":"1997","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0027|cit27","first-page":"496","article-title":"Treatment of american cutaneous leishmaniasis: a comparison between low dosage (5mg\/kg\/day) and high dosage (20 mg\/kg\/day) antimony regimens","volume":"45","author":"Oliveira-Neto","year":"1997","journal-title":"Pathologie et Biologie"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4269\/ajtmh.1985.34.856","article-title":"American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules","volume":"34","author":"Oster","year":"1985","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"3, 4","key":"10.1002\/14651858.CD004834.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimoniate for cutaneous leishmaniasis due to leishmania viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0030|cit30","first-page":"148","article-title":"Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis","volume":"12","author":"Saenz","year":"1987","journal-title":"Revista M\u00e9dica de Panam\u00e1"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1086\/424848","article-title":"Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study","volume":"190","author":"Santos","year":"2004","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0035-9203(94)90235-6","article-title":"Limited efficacy of injectable aminosidine as single-agent therapy for colombian cutaneous leishmaniasis","volume":"88","author":"Soto","year":"1994","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/516267","article-title":"Topical paromomycin\/methylbenzethonium chloride plus parenteral meglumine antimoniate as treatment for american cutaneous leishmaniasis: controlled study","volume":"26","author":"Soto","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","article-title":"Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study","volume":"66","author":"Soto","year":"2002","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-126-3-199702010-00010","article-title":"Inefficacy of allopurinol as monotherapy for colombian cutaneous leishmaniasis: a randomized, controlled trial","volume":"126","author":"Velez","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogeneicity, and efficacy of an autoclaved leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"Armijos","year":"2004","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis","volume":"17","author":"Luca","year":"1999","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0001-706X(01)00181-4","article-title":"A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis","volume":"80","author":"Luca","year":"2001","journal-title":"Acta Tropica"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0035-9203(03)80109-8","article-title":"Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test","volume":"97","author":"Luca","year":"2003","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1590\/S0037-86822000000600004","article-title":"Evaluation of the efficacy and toxicity of N-methyl-glucantime vs BP88 Sodium Stibogluconate in the treatment of localized cutaneous leishmaniasis","volume":"33","author":"Deps","year":"2000","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.actatropica.2006.11.007","article-title":"Skin reactivity to thimerosal and phenol-preserved Montenegro antigen in Brazil","volume":"101","author":"Fagundes","year":"2007","journal-title":"Acta Tropica"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0035-9203(94)90432-4","article-title":"Hepatotoxicity of sodium stibogluconate therapy for American cutaneous leishmaniasis","volume":"88","author":"Hepburn","year":"1994","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/S0037-86821999000500010","article-title":"Efficacy of mefloquine in the treatment of skin leishmaniasis in an endemic area of leishmania (viannia) braziliensis","volume":"32","author":"Laguna-Torres","year":"1999","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.1991.214","article-title":"Effect of salt supplementation on amphotericin B nephrotoxicity","volume":"40","author":"Llanos","year":"1991","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1590\/S0074-02761994000300034","article-title":"Exploitation of parasite derived antigen in therapeutic success of human cutaneous leishmaniasis in Brazil","volume":"89","author":"Monjour","year":"1994","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"issue":"7","key":"10.1002\/14651858.CD004834.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1128\/IAI.58.7.2198-2203.1990","article-title":"Vaccination of humans against cutaneous leishmaniasis: cellular and humoral inmune responses","volume":"58","author":"Nascimento","year":"1990","journal-title":"Infection and Immunity"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S0036-46652000000600004","article-title":"Mucosal leishmaniasis (\"espundia\") responsive to low dose of N-methyl glucantime in Rio de Janeiro, Brazil","volume":"42","author":"Oliveira-Neto","year":"2000","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"},{"issue":"4","key":"10.1002\/14651858.CD004834.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1590\/S0074-02761995000400020","article-title":"A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis","volume":"90","author":"Rodriguez","year":"1995","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"issue":"4","key":"10.1002\/14651858.CD004834.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0037-86822000000400009","article-title":"Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity","volume":"33","author":"Saldanha","year":"2000","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/clind\/16.3.417","article-title":"Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia","volume":"16","author":"Soto-Mancipe","year":"1993","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4269\/ajtmh.1994.50.107","article-title":"Successful treatment of colombian cutaneous leishmaniasis with four injections of pentamidine","volume":"50","author":"Soto","year":"1994","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trstmh.2005.04.002","article-title":"Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia","volume":"99","author":"Velez","year":"2005","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004834.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4269\/ajtmh.2007.77.640","article-title":"A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis","volume":"77","author":"Krolewiecki","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0059|cit59","unstructured":"Maguire JH Phase II Randomized Study of Allopurinol Versus Glucantime Versus Allopurinol\/Glucantime for Cutaneous Leishmaniasis in Brazil ClinicalTrials.gov 1995"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0060|cit60","unstructured":"Llanos Cuentas A A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability, and Immunogenicity of Leish-111f + MPL-SE Vaccine in Combination With Pentavalent Antimony in Treatment of Mucosal Leishmaniasis ClinicalTrials.gov 2004"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0061|cit61","unstructured":"Nascimento E Piazza FM Randomized, Double-Blind, Adjuvant- and Placebo-Controlled, Dose-Escalating Study to Evaluate Safety, Tolerability, and Immunogenicity of Leish-111f + MPL-SE Vaccine With Meglumine Antimoniate (Glucantime) in Cutaneous Leishmaniasis ClinicalTrials.gov 2004"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0062|cit62","unstructured":"Piazza FM A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Leish-111f + MPL-SE Vaccine Compared to the Leish-111f Protein Alone in Montenegro Skin Test-Negative Healthy Adults ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0063|cit63","unstructured":"Soto J Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia ClinicalTrials.gov 2005"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0064|cit64","unstructured":"Llanos-Cuentas A Randomized Double Blind Clinical Trial of Imiquimod (Aldara) Versus Placebo Used in Combination With Pentavalent Antimony (Glucantime) in Peruvian Cutaneous Leishmaniasis Patients ClinicalTrials.gov 2005"},{"issue":"7","key":"10.1002\/14651858.CD004834.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-6215-7-14","article-title":"Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]","volume":"15","author":"Silva","year":"2006","journal-title":"Trials"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0066|cit66","unstructured":"Romero GS Phase IV Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of Low-Dose Pentavalent Antimony Compared to the Standard Dose in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)Braziliensis ClinicalTrials.gov 2006"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0067|cit67","unstructured":"Carvalho EM Marshall JG Empiric Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Trial in Subjects Co-Infected With Helminths and Leishmania Brasiliensis ClinicalTrials.gov 2007"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0068|cit68","unstructured":"Lopez L Phase 3 Open-Label Study of Efficacy and Safety of Miltefosine vs Glucantime for Cutaneous Leishmaniasis in Colombia. ClinicalTrials.gov 2006"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0069|cit69","unstructured":"Miranda MC Rodriguez I Randomized Clinical Trial of the Efficacy and Tolerability of Oral Miltefosine Versus Parenteral Antimony for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia ClinicalTrials.gov 2007"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Soto J Toledo J Efficacy and safety of a short course of the combination of miltefosine and antimony to treat cutaneous leishmaniasis in Bolivia ClinicalTrials.gov 2007","DOI":"10.1016\/S1473-3099(06)70665-X"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0071|cit71","unstructured":"Machado PRL Clinical Trial to Assess Efficacy and Safety of Orally Administered Miltefosine in Brazilian Patients With Cutaneous Leishmaniasis Compared to the Standard Care as Active Control ClinicalTrials.gov 2008"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0072|cit72","unstructured":"Rabello A Pedras M Open Label Randomized Study to Assess Safety and Efficacy of Azithromycin Versus Meglumine Antimoniate to Treat Cutaneous Leishmaniasis ClinicalTrials.gov 2008"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0934-8840(96)80027-2","article-title":"Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor","volume":"285","author":"Al-Zamel","year":"1996","journal-title":"Zentralblatt f\u00fcr Bakteriologie : international journal of medical microbiology"},{"issue":"12","key":"10.1002\/14651858.CD004834.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends in Parasitology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The Relationship between Leishmaniasis and AIDS: The Second 10 Years.","volume":"2","author":"Alvar","year":"2008","journal-title":"Clinical Microbiology Review"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.2007.77.266","article-title":"Treatment of mucosal leishmaniasis in Latin America: systematic review","volume":"77","author":"Amato","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"11","key":"10.1002\/14651858.CD004834.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02349.x","article-title":"Evaluation of CO2 laser efficacy in the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2307\/3285616","article-title":"Detection and identification of Leishmania parasites in clinical specimens in Ecuador: A comparison with classical diagnostic methods","volume":"85","author":"Aviles","year":"1999","journal-title":"Journal of Parasitology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0080|cit80","first-page":"103","article-title":"Treatment of cutaneous leishmaniasis using a carbon dioxide laser","volume":"69","author":"Babajev","year":"1991","journal-title":"Bulletin of the World Health Organization"},{"issue":"8","key":"10.1002\/14651858.CD004834.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/507708","article-title":"Immunotherapy for drug-refractory mucosal leishmaniasis","volume":"194","author":"Badaro","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004630-199509000-00013","article-title":"The Vancouver Scar Scale: an administration tool and its interrater reliability","volume":"16","author":"Baryza","year":"1995","journal-title":"The Journal of Burn Care & Rehabilitation"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4269\/ajtmh.1981.30.318","article-title":"Effect of temperature on multiplication of Leishmania amastigotes within monocyte-derived macrophages in vitro","volume":"30","author":"Berman","year":"1981","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0738-081X(96)00048-X","article-title":"Treatment of New World cutaneous and mucosal leishmaniases","volume":"14","author":"Berman","year":"1996","journal-title":"Clinics in Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD004834.pub2-BIB0085|cit85","first-page":"1381","article-title":"Miltefosine to treatment leishmaniasis: drug evaluation","volume":"6","author":"Berman","year":"2005","journal-title":"Expert Opinion on Investigational drugs"},{"issue":"7","key":"10.1002\/14651858.CD004834.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis","volume":"43","author":"Bern","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0035-9203(99)90346-2","article-title":"Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-east Brazil","volume":"93","author":"Brandao-Filho","year":"1999","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archderm.139.6.795","article-title":"Appraising Systematic Reviews and Meta-analyses","volume":"139","author":"Bigby","year":"2003","journal-title":"Archives of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD004834.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nature reviews. Microbiology"},{"issue":"11","key":"10.1002\/14651858.CD004834.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends in parasitology"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0091|cit91","first-page":"399","article-title":"Current scenario of drug development for Leishmaniasis","volume":"123","author":"Croft","year":"2006","journal-title":"The Indian Journal of Medical Research"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1590\/S0102-311X2000000400013","article-title":"The epidemiology and control of leishmaniasis in Andean countries.","volume":"16(4)","author":"Davies","year":"2000","journal-title":"Cadernos de sa\u00fade p\u00fablica \/ Minist\u00e9rio da Sa\u00fade, Funda\u00e7\u00e3o Oswaldo Cruz, Escola Nacional de Sa\u00fade P\u00fablica"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","article-title":"Leishmaniasis: public health aspects and control","volume":"14","author":"Desjeux","year":"1996","journal-title":"Clinical Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S0037-86821991000400005","article-title":"Parasitological diagnosis of mucocutaneous leishmaniasis due to Leishmania braziliensis in Bolivia","volume":"24","author":"Dimier-David","year":"1991","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/00494755920220S110","article-title":"American cutaneous and mucocutaneous leishmaniasis (tegumentary): A diagnostic challenge","volume":"22 Suppl 1","author":"Escobar","year":"1992","journal-title":"Tropical Doctor"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0035-9203(94)90518-5","article-title":"Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds","volume":"88","author":"Falcoff","year":"1994","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"8","key":"10.1002\/14651858.CD004834.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.73.8.4948-4954.2005","article-title":"Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D\/A oligodeoxynucleotides expressing CpG motifs","volume":"73","author":"Flynn","year":"2005","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0098|cit98","first-page":"619","article-title":"Allopurinol in the treatment of zoonotic cutaneous leishmaniasis","volume":"26","author":"Ghanem","year":"1996","journal-title":"Journal of the Egyptian Society of Parasitology"},{"issue":"7589","key":"10.1002\/14651858.CD004834.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bmj.39070.527986.68","article-title":"When are randomised trials unnecessary? Picking signal from noise","volume":"334","author":"Glasziou","year":"2007","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD004834.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005067.pub3","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"Gonz\u00e1lez","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actatropica.2004.10.007","article-title":"Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis","volume":"93","author":"Gon\u00e7alves","year":"2005","journal-title":"Acta Tropica"},{"issue":"7591","key":"10.1002\/14651858.CD004834.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/bmj.39136.475313.FA","article-title":"Beware the \"Texas sharp shooter\" in rate ratios of progression","volume":"334","author":"Goodman","year":"2007","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","article-title":"Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin","volume":"85","author":"Grogl","year":"1999","journal-title":"The Journal of Parasitology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00001432-200104000-00007","article-title":"Management of cutaneous leishmaniasis","volume":"14","author":"Hepburn","year":"2001","journal-title":"Current Opinion in Infectious Diseases"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"7139","key":"10.1002\/14651858.CD004834.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.316.7139.1200","article-title":"Randomised controlled trial of aminosidine v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India - paromomycin","volume":"316","author":"Jha","year":"1998","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.1986.tb00425.x","article-title":"Cutaneous leishmaniasis from Belize--treatment with ketoconazole","volume":"11","author":"Jolliffe","year":"1986","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4362.1986.tb03460.x","article-title":"Treatment of cutaneous leishmaniasis with infrared heat","volume":"25","author":"Junaid","year":"1986","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.1992.01680160041003","article-title":"Cutaneous leishmaniasis treated with controlled localized heating","volume":"128","author":"Levine","year":"1992","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trstmh.2003.08.001","article-title":"Risk factors for mucosal manifestation of American cutaneous leishmaniasis","volume":"99","author":"Machado-Coelho","year":"2005","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1468-3083.1997.tb00487.x","article-title":"Selective heat therapy in cutaneous leishmaniasis: a preliminary experience using the 585 nm pulsed dye laser","volume":"8","author":"Meawad","year":"1997","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Medicine and Infectious Disease"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9292-6-3","article-title":"Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006","volume":"6","author":"Modabber","year":"2006","journal-title":"Kinetoplastid Biology and Disease"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/jm030868a","article-title":"Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone","volume":"47","author":"M\u00e4ntyl\u00e4","year":"2004","journal-title":"Journal of Medicinal Chemistry"},{"issue":"22","key":"10.1002\/14651858.CD004834.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1016\/S0021-9258(19)86518-3","article-title":"Allopurinol ribonucleoside as an antileishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation","volume":"254","author":"Nelson","year":"1979","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4269\/ajtmh.1984.33.800","article-title":"Observations on local heat treatment for cutaneous leishmaniasisObservations on local heat treatment for cutaneous leishmaniasis","volume":"33","author":"Neva","year":"1984","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0037-86822001000100002","article-title":"Cutaneous leishmaniasis in the Metropolitan Region of Belo Horizonte: clinical, laboratorial, therapeutic and prognosis features (1989-1995)","volume":"34(1)","author":"Passos","year":"2001","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/JCM.37.6.1819-1823.1999","article-title":"Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil","volume":"37","author":"Pirmez","year":"1999","journal-title":"Journal of Clinical Microbiology"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-9292-2-14","article-title":"Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy","volume":"2","author":"Ponte Sucre","year":"2003","journal-title":"Kinetoplastid Biology and Disease"},{"issue":"1","key":"10.1002\/14651858.CD004834.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/S0037-86822003000100010","article-title":"Efficacy of azithromycin in the treatment of cutaneous leishmaniasis","volume":"36","author":"Prata","year":"2003","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"9","key":"10.1002\/14651858.CD004834.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"The Lancet Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD004834.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1471-4922(02)02387-5","article-title":"Strategic emphases for tropical diseases research: a TDR perspective","volume":"18","author":"Remme","year":"2002","journal-title":"Trends in Parasitology"},{"issue":"10","key":"10.1002\/14651858.CD004834.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0966-842X(02)02431-9","article-title":"Strategic emphases for tropical diseases research: a TDR prespective","volume":"10","author":"Remme","year":"2002","journal-title":"Trends in Microbiology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0126|cit126","first-page":"197","article-title":"Treatment of cutaneous leishmaniasis with CO2 laser radiation","volume":"42","author":"Rodriguez","year":"1990","journal-title":"Revista Cubana de Medicina Tropical"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1590\/S0037-86821996000600005","article-title":"Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis","volume":"29","author":"Romero","year":"1996","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4269\/ajtmh.1983.32.300","article-title":"Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro","volume":"32","author":"Sacks","year":"1983","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S0037-86821997000200007","article-title":"Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B","volume":"30","author":"Sampaio","year":"1997","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1371\/journal.pmed.0030283","article-title":"Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization","volume":"3","author":"Savioli","year":"2006","journal-title":"PLoS medicine"},{"issue":"11","key":"10.1002\/14651858.CD004834.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/qjmed\/92.11.659","article-title":"Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis","volume":"92","author":"Seaton","year":"1999","journal-title":"QJM : monthly journal of the Association of Physicians"},{"issue":"6","key":"10.1002\/14651858.CD004834.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10156-004-0348-9","article-title":"Challenges and new discoveries in the treatment of leishmaniasis","volume":"10","author":"Singh","year":"2004","journal-title":"Journal of Infection and Chemotherapy : official journal of the Japan Society of Chemotherapy"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD004834.pub2-BIB0134|cit134","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in Indi","volume":"83","author":"Sundar","year":"2005","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0135|cit135","first-page":"345","article-title":"Visceral leishmaniasis - current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"The Indian Journal of Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD004834.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-4632.2008.03417.x","article-title":"Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis","volume":"109","author":"Tuon","year":"2008","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1346-8138.1998.tb02470.x","article-title":"Comparative studies of the detection rates of Leishmania parasites from formalin, ethanol-fixed, frozen human skin specimens by polymerase chain reaction and Southern blotting","volume":"25","author":"Uezato","year":"1988","journal-title":"Journal of Dermatology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-4362.1982.tb03163.x","article-title":"Oral ketoconazole in the treatment of cutaneous leishmaniasis","volume":"21","author":"Urcuyo","year":"1982","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD004834.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4269\/ajtmh.1997.57.309","article-title":"Treatment of cutaneous leishmaniasis with localized current field (radiofrequency) in Tabasco, Mexico","volume":"57","author":"Velasco-Castrejon","year":"1997","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"10","key":"10.1002\/14651858.CD004834.pub2-BIB0140|cit140","first-page":"1291","article-title":"Consensus panel recommendations for chronic and acute wound dressings","volume":"143","author":"Vaneau","year":"2007","journal-title":"Archives of Dermatolology"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0141|cit141","first-page":"59","article-title":"The leishmaniasis","volume":"793","author":"WHO","year":"1990","journal-title":"World Health Organization Technical Report Service"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0142|cit142","unstructured":"World Health Organization WHO Report on global surveillance of epidemic-prone infectious diseases http:\/\/www.who.int\/emc-documents\/surveillance\/docs\/whocdscsrisr2001.html\/Leishmaniasis\/Leishmaniasis.htm 2001"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0143|cit143","unstructured":"WHO World Health Report 2002 http:\/\/www.who.int\/whr\/2002\/annex\/en\/ 2002"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0144|cit144","unstructured":"World Heald Organisation Control of leishmaniasis. Report by the Secretariat http:\/\/ftp.who.int\/gb\/ebwha\/pdf_files\/WHA60\/A60_10-en.pdf"},{"key":"10.1002\/14651858.CD004834.pub2-BIB0145|cit145","unstructured":"World Health Organization (WHO) Report of the Fifth Consultatve Meeting on HIV-Leishmania co-infection. Addis Ababa, 20 to 22 March 2007 WHO\/CDS\/NTD\/IDM\/2007 2008 (in press)"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004834.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004834.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:12:05Z","timestamp":1633309925000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004834.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":145,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004834.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}